Very Late Thrombosis After Bioresorbable Scaffolds Cause for Concern?

被引：42
作者：
Stone, Gregg W. [1 ,2 ]
Granada, Juan F. [1 ,3 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY 10022 USA
[2] Cardiovasc Res Fdn, New York, NY USA
[3] Cardiovasc Res Fdn, Skirball Ctr Innovat, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 17期
关键词：
bioresorbable scaffold; coronary artery disease; optical coherence tomography; thrombosis; OPTICAL COHERENCE TOMOGRAPHY; CORONARY-ARTERY LESIONS; CLINICAL-EVALUATION; VASCULAR SCAFFOLD; STENT SYSTEM; IMPLANTATION; MODEL; TRIAL; OUTCOMES; SAFETY;
D O I：
10.1016/j.jacc.2015.08.863
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1915 / 1917
页数：3
相关论文
共 14 条
  • [1] Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12-18, 24-, 30-, 36-and 42-month follow-up in a porcine model
    Campos, Carlos M.
    Ishibashi, Yuki
    Eggermont, Jeroen
    Nakatani, Shimpei
    Cho, Yun Kyeong
    Dijkstra, Jouke
    Reiber, Johan H. C.
    Sheehy, Alexander
    Lane, Jennifer
    Kamberi, Marika
    Rapoza, Richard
    Perkins, Laura
    Garcia-Garcia, Hector M.
    Onuma, Yoshinobu
    Serruys, Patrick W.
    [J]. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2015, 31 (03) : 471 - 482
  • [2] 5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents Final Results From the SPIRIT III Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)
    Gada, Hemal
    Kirtane, Ajay J.
    Newman, William
    Sanz, Mark
    Hermiller, James B.
    Mahaffey, Kenneth W.
    Cutlip, Donald E.
    Sudhir, Krishnankutty
    Hou, Liming
    Koo, Kai
    Stone, Gregg W.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (12) : 1263 - 1266
  • [3] Safety and Efficacy of Drug-Eluting and Bare Metal Stents Comprehensive Meta-Analysis of Randomized Trials and Observational Studies
    Kirtane, Ajay J.
    Gupta, Anuj
    Iyengar, Srinivas
    Moses, Jeffrey W.
    Leon, Martin B.
    Applegate, Robert
    Brodie, Bruce
    Hannan, Edward
    Harjai, Kishore
    Jensen, Lisette Okkels
    Park, Seung-Jung
    Perry, Raphael
    Racz, Michael
    Saia, Francesco
    Tu, Jack V.
    Waksman, Ron
    Lansky, Alexandra J.
    Mehran, Roxana
    Stone, Gregg W.
    [J]. CIRCULATION, 2009, 119 (25) : 3198 - U78
  • [4] Longitudinal stent deformation: insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience database
    Mamas, Mamas A.
    Williams, Paul D.
    [J]. EUROINTERVENTION, 2012, 8 (02) : 196 - 204
  • [5] Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
    McFadden, EP
    Stabile, E
    Regar, E
    Cheneau, E
    Ong, ATL
    Kinnaird, T
    Suddath, WO
    Weissman, NJ
    Torguson, R
    Kent, KM
    Pichard, AD
    Satler, LF
    Waksman, R
    Serruys, PW
    [J]. LANCET, 2004, 364 (9444) : 1519 - 1521
  • [6] Why are we so concerned with acute incomplete stent apposition?
    Mintz, Gary S.
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2015, 16 (01) : 110 - 111
  • [7] A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
    Morice, M
    Serruys, PW
    Sousa, JE
    Fajadet, J
    Hayashi, EB
    Perin, M
    Colombo, A
    Schuler, G
    Barragan, P
    Guagliumi, G
    Molnar, F
    Falotico, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) : 1773 - 1780
  • [8] Stent Fracture After Sirolimus-Eluting Stent Implantation 8-Year Clinical Outcomes
    Ohya, Masanobu
    Kadota, Kazushige
    Tada, Takeshi
    Habara, Seiji
    Shimada, Takenobu
    Amano, Hidewo
    Izawa, Yu
    Hyodo, Yusuke
    Miyake, Koshi
    Otsuru, Suguru
    Hasegawa, Daiji
    Tanaka, Hiroyuki
    Maruo, Takeshi
    Katoh, Harumi
    Fuku, Yasushi
    Goto, Tsuyoshi
    Mitsudo, Kazuaki
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (08)
  • [9] Incidence and Imaging Outcomes of Acute Scaffold Disruption and Late Structural Discontinuity After Implantation of the Absorb Everolimus-Eluting Fully Bioresorbable Vascular Scaffold Optical Coherence Tomography Assessment in the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)
    Onuma, Yoshinobu
    Serruys, Patrick W.
    Muramatsu, Takashi
    Nakatani, Shimpei
    van Geuns, Robert-Jan
    de Bruyne, Bernard
    Dudek, Dariusz
    Christiansen, Evald
    Smits, Pieter C.
    Chevalier, Bernard
    McClean, Dougal
    Koolen, Jacques
    Windecker, Stephan
    Whitbourn, Robert
    Meredith, Ian
    Garcia-Garcia, Hector M.
    Veldhof, Susan
    Rapoza, Richard
    Ormiston, John A.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (12) : 1400 - 1411
  • [10] Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model An Attempt to Decipher the Human Optical Coherence Tomography Images in the ABSORB Trial
    Onuma, Yoshinobu
    Serruys, Patrick W.
    Perkins, Laura E. L.
    Okamura, Takayuki
    Gonzalo, Nieves
    Garcia-Garcia, Hector M.
    Regar, Evelyn
    Kamberi, Marika
    Powers, Jennifer C.
    Rapoza, Richard
    van Beusekom, Heleen
    van der Giessen, Willem
    Virmani, Renu
    [J]. CIRCULATION, 2010, 122 (22) : 2288 - 2300
12